Medtronic Heart Valves Division

Form 483 issued March 30, 2016 · Santa Ana, California

Inspection
Mar 15 – Mar 30, 2016
Investigator
Kirtida Patel
Observations
2
Pages
2
FEI number
2025587

In short: On March 30, 2016, FDA issued a Form 483 with 2 observations to Medtronic Heart Valves Division in Santa Ana, California (FEI 2025587) after an inspection that ran Mar 15 – Mar 30, 2016. The investigator was Kirtida Patel. Most observations concern production & process controls; the most-cited regulation is 21 CFR 820.70 (production and process controls).

At a glance

Observations span 1 system, led by production & process controls.

Production & process controls1
Other1

Most cited: 21 CFR 820.70(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Process control procedures that describe any process controls necessary to ensure conformance to specifications have…

  2. 02

    : Not…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Medtronic Heart Valves Division?

FDA listed 2 observations on this Form 483, mostly about production & process controls. The most-cited regulation is 21 CFR 820.70 (production and process controls). The opening words of each observation are shown on this page.

Who inspected Medtronic Heart Valves Division?

Kirtida Patel is named on this Form 483, for the inspection of Mar 15 – Mar 30, 2016. Each investigator has a profile showing what they cite most.

When was Medtronic Heart Valves Division inspected by FDA?

The inspection ran Mar 15 – Mar 30, 2016, and the Form 483 is dated March 30, 2016.

How do I get the full Form 483 for Medtronic Heart Valves Division?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free